AR

Abhishek Rao

Active Director Director DIN 10772222
DIN 10772222 First appointment Nov 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value •••• Premium profile

About Abhishek Rao

Data last updated:

Abhishek Rao is a Director at Aveerax Biotech Private Limited (since 2024). The company operates in Pharma. Aveerax Biotech Private Limited reported revenue of ₹13.3 Lakh (FY 2025).

DIN 10772222
Primary Designation Director
Industry Pharma
First Appointment 27 Nov 2024
Oldest Company Age 3 yrs
Largest company Aveerax Biotech Private Limited · ₹13.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aveerax Biotech Private Limited U46497DL2023PTC411941
Director27 Nov 20242023₹13.3 Lakh (FY 2025)Active

Board colleagues of Abhishek Rao

Directorship timeline

Open interactive timeline →
Aveerax Biotech Private Limited
Premium access

Shareholding and investment profile for Abhishek Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Rao

Abhishek Rao currently holds 1 directorship: Aveerax Biotech Private Limited (Director, since 27 Nov 2024, revenue ₹13.3 Lakh (FY 2025)).

Abhishek Rao was first appointed on 27 Nov 2024 as Director at Aveerax Biotech Private Limited.

The current boards of Abhishek Rao's companies include Indu Devi (Aveerax Biotech Private Limited), Rakesh Kumar Rao (Aveerax Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available